Advances in FIP treatment, an Australia perspective (2021)
Overview
Advances in anti-viral therapy are showing that effective treatment for FIP is finally a reality. Since 2018, emerging studies have demonstrated remission rates of up to 80% using novel antiviral drugs.
While no registered commercial treatments are currently available, legal access to remdesivir—a nucleoside analogue—via BOVA’s compounding pharmacy is offering a promising option for veterinarians. Additionally, mefloquine, a human-registered antimalarial, may also have a role in FIP therapy.
In this webinar, Dr Sally Coggins of the Sydney School of Veterinary Science will:
- Share clinical insights from current treatment trials
- Outline commonly used protocols and dosages
- Discuss potential side effects and how to handle treatment failures
This is a must-watch update for any vet managing feline patients with suspected or confirmed FIP.
Dr. Sally Coggins BVSc (hons I) MANZCVS (Feline Medicine)
Dr Sally Coggins graduated with first-class honours from The University of Sydney in 2007. After two years in small animal practice in Canberra, she joined The Cat Clinic in Prahran (Melbourne) in 2010, where she spent a decade working in feline-only practice. During her time there, Sally became a partner and director, managing a high volume of both first-opinion and referral feline cases.
In 2012, she attained membership in Feline Medicine with the Australian and New Zealand College of Veterinary Scientists (ANZCVS) and went on to serve as an examiner for the College in 2016, 2017, and 2018.
Sally is now focused on clinical research, having commenced a full-time master’s degree at the Sydney School of Veterinary Science under the supervision of Professor Jacqueline Norris, Associate Professor Merran Govendir, and Associate Professor Mary Thompson. Her current work investigates novel antiviral therapies for Feline Infectious Peritonitis (FIP), and she is leading ongoing clinical trials open to national recruitment.
She continues to see feline patients one day per week at Gordon Veterinary Hospital, and she also teaches as a feline medicine distance education tutor for the Centre for Veterinary Education and as an undergraduate tutor for DVM students at The University of Sydney.
Lizzie Barnard
Head of Marketing- Bova Group
Lizzie has over 10 years experience within the veterinary pharmaceutical industry in product management and marketing roles. Mainly in equine and small animal species. Before this Lizzie had a career in the horse racing industry working as a head girl for prolific trainers.
Lizzie is developing the Bova brand to ensure that the company is represented in a consistent manner across the veterinary industry.
